Design of Experiments & Formulation Optimization
Learning to efficiently screen multiple factors in pharmaceutical formulation development
By the end of this workshop, you will be able to:
Factor screening is the systematic process of identifying which variables (factors) have significant effects on your response variables from a larger set of potential factors.
Why is it crucial in pharmaceutical development?
Scenario: A pharmaceutical company is developing a new immediate-release tablet and needs to screen potential factors affecting dissolution rate.
Factors to screen:
Traditional approach: Testing all combinations = 2×3×2×4×3×3×4 = 1,728 experiments!
Screening approach: Fractional factorial = 8-16 experiments
Let's think step-by-step about what this notation means:
Resolution determines what effects you can estimate clearly:
Resolution III: Main effects confounded with 2-factor interactions
Resolution IV: Main effects clear, 2-factor interactions confounded with each other
Resolution V: Main effects and 2-factor interactions are clear
Scenario: Screen 5 factors affecting tablet hardness using a 2^(5-1) fractional factorial design (16 runs).
Factors and Levels:
Factor | Low Level (-1) | High Level (+1) | Units |
---|---|---|---|
A: Binder % | 2 | 4 | %w/w |
B: Compression Force | 8 | 16 | kN |
C: Lubricant % | 0.5 | 1.5 | %w/w |
D: Dwell Time | 1 | 3 | seconds |
E: Granulation | Wet | Dry | Method |
Step 1: Choose the Generator
Step 2: Create the Basic 2^4 Matrix
Step 3: Generate Column E
When E = A×B×C×D, the defining relation is I = A×B×C×D×E
Complete alias structure:
Interpretation: If you see a large "A effect," it could be due to factor A OR the 4-factor interaction B×C×D×E (unlikely but possible).
Problem: After running your 2^(5-1) design, you find that factors A and B appear significant, but you're concerned about potential A×B interaction being confounded.
Solution: Fold-Over Design
Step 1: Run the "mirror image" of your original design
Step 2: Change the signs of ALL factors in every run
Step 3: Combine data from both halves
Result: Main effects separated from 2-factor interactions!
Plackett-Burman designs are perfect when:
12-Run Plackett-Burman Base Row:
This base row is cyclically shifted to create 11 rows, plus one row of all minus signs.
Run | A | B | C | D | E | F | G | H | I | J | K |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | + | + | - | + | + | + | - | - | - | + | - |
2 | + | - | + | + | + | - | - | - | + | - | + |
3 | - | + | + | + | - | - | - | + | - | + | + |
... (continue cyclic shifts) ... | |||||||||||
12 | - | - | - | - | - | - | - | - | - | - | - |
Scenario: Screen 11 factors affecting capsule disintegration time using 12-run P-B design.
Factors to screen:
Complex confounding pattern: Unlike fractional factorials, P-B designs have complex alias structures where main effects are partially confounded with many interactions.
When to be cautious:
Best practice: Use P-B for initial screening, then follow up significant factors with fractional factorial or RSM designs.
Our mission: Separate the "vital few" factors that significantly affect our response from the "trivial many" that don't.
Two powerful visualization tools help us achieve this:
Lenth's Method for significance threshold:
Where PSE = Pseudo Standard Error, ME = Margin of Error, SME = Simultaneous Margin of Error
Scenario: Analyze results from 2^(5-1) screening design for tablet dissolution rate (% dissolved at 30 min).
Step 1: Raw Data Summary
Factor | Average at Low Level | Average at High Level | Effect | |Effect| |
---|---|---|---|---|
A: Binder % | 82.3% | 78.1% | -4.2% | 4.2% |
B: Compression Force | 85.2% | 75.2% | -10.0% | 10.0% |
C: Lubricant % | 79.8% | 80.6% | +0.8% | 0.8% |
D: Dwell Time | 84.1% | 76.3% | -7.8% | 7.8% |
E: Granulation | 78.9% | 81.5% | +2.6% | 2.6% |
Step 2: Apply Lenth's Method
Step 3: Identify Significant Effects
Effects exceeding ME (9.45%):
Effects below threshold:
Step 4: Pharmaceutical Interpretation
Compression Force (Factor B) is the dominant factor:
The half-normal plot principle:
What to look for:
The final step: Use screening results to select 2-4 factors for detailed optimization studies (RSM).
Selected for optimization:
Next step: Design a Response Surface Methodology (RSM) study with these 3 factors.
You've identified the critical factors - now let's optimize them!
In Part 3: Full Factorial Design Center, we'll learn how to:
Before moving on, ask yourself:
If you can answer these confidently, you're ready for Part 3!
You've mastered the art of efficient factor screening in pharmaceutical development.
Ready for Part 3: Full Factorial Design Center? →